Search Results - "Schmitz, B J"

DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas by FLORL, A. R, LÖWER, R, SCHMITZ-DRÄGER, B. J, SCHULZ, W. A

“…Since DNA methylation is considered an important mechanism for silencing of retroelements in the mammalian genome, hypomethylation in human tumours may lead to…”
Get full text

Epidemiology of urinary bladder cancer : from tumor development to patient's death by MURTA-NASCIMENTO, Cristiane, SCHMITZ-DRÄGER, Bernd J, ZEEGERS, Maurice P, STEINECK, Gunnar, KOGEVINAS, Manolis, REAL, Francisco X, MALATS, Nuria

“…Urinary bladder cancer (UBC) ranks ninth in worldwide cancer incidence. It is more frequent in men than in women. We review the main established/proposed…”
Get full text

Frequent and heterogenous expression of cyclin-dependent kinase inhibitor WAF1/p21 protein and mRNA in urothelial carcinoma by CLASEN, S, SCHULZ, W. A, GERHARZ, C.-D, GRIMM, M.-O, CHRISTOPH, F, SCHMITZ-DRÄGER, B. J

“…The inhibitor of cyclin-dependent kinases WAF1/p21 has been shown to mediate cell cycle arrest by p53 and other factors. We have studied its expression in…”
Get full text

Over‐expression and amplification of the c‐myc gene in human urothelial carcinoma by Christoph, Frank, Schmidt, Bettina, Schmitz‐Dräger, Bernd J., Schulz, Wolfgang A.

“…To understand the mechanisms underlying increased expression of Myc protein in human urinary bladder cancer, expression of c‐myc mRNA and the copy number of…”
Get full text

Bladder cancer markers in patient management: the current perspective by Schmitz-Dräger, B. J., Fradet, Y., Grossman, H. B.

Get full text

Immunocytology in the assessment of patients with asymptomatic hematuria by Schmitz-Dräger, B. J., Tirsar, L. -A., Schmitz-Dräger, C., Dörsam, J., Mellan, Z., Bismarck, E., Ebert, T.

“…Painless hematuria has remained a diagnostic challenge in daily urological practice. Key problem in the assessment of these patients is the discrimination…”
Get full text

Dual-parameter immunoflow cytometry in diagnosis and follow-up of patients with bladder cancer by Jankevicius, F, Shibayama, T, Decken, K, Bojar, H, Gerharz, C D, Ebert, T, Ackermann, R, Schmitz-Dräger, B J

“…The aim of this study was to evaluate the clinical significance of a dual-parameter immunoflow cytometry (DPI-FCM) assay in the detection of tumor cells in…”
Get more information

Expression of basic fibroblast growth factor in primary human renal tumors: correlation with poor survival by Nanus, D M, Schmitz-Dräger, B J, Motzer, R J, Lee, A C, Vlamis, V, Cordon-Cardo, C, Albino, A P, Reuter, V E

Get more information

p53 and MDM2 in the development and progression of bladder cancer by Schmitz-Dräger, B J, Kushima, M, Goebell, P, Jax, T W, Gerharz, C D, Bültel, H, Schulz, W A, Ebert, T, Ackermann, R

“…Earlier investigations have demonstrated that inactivation of the p53 tumor suppressor gene might play a role in the development and progression of bladder…”
Get more information

Seasonal Movements, Habitat Use, Aggregation, Exploitation, and Entrainment of Saugers in the Lower Yellowstone River: An Empirical Assessment of Factors Affecting Population Recovery by Jaeger, Matthew E., Zale, Alexander V., McMahon, Thomas E., Schmitz, Brad J.

“…Migratory barriers, habitat loss, entrainment in irrigation canals, and overexploitation, especially at times of aggregation, have been suggested to explain…”
Get full text

Monoclonal antibody Due ABC 3 directed against transitional cell carcinoma. II. Prospective trial on the diagnostic value of immunocytology using monoclonal antibody Due ABC 3 by Schmitz-Dräger, B J, Nakamura, S, Decken, K, Pfitzer, P, Rottmann-Ickler, C, Ebert, T, Ackermann, R

“…Recently, the development of monoclonal antibody Due ABC 3 directed against transitional cell carcinoma has been reported. With this monoclonal antibody an in…”
Get more information

Monoclonal antibody Due ABC 3 directed against transitional cell carcinoma. I. Production, specificity analysis, and preliminary characterization of the antigen by Decken, K, Schmitz-Dräger, B J, Rohde, D, Nakamura, S, Ebert, T, Ackermann, R

“…The development of the hybridoma technology allows the identification of tumor associated antigens with monoclonal antibodies (mAbs). Employing this technology…”
Get more information

Rationale Nachsorge des nicht-muskelinvasiven Harnblasenkarzinoms by von Landenberg, N., Benderska-Söder, N., Bismarck, E., Kernig, K., Erne, E., Goebell, P. J., Schmitz-Dräger, B. J.

“…Zusammenfassung Hintergrund Die Nachsorge des nicht-muskelinvasiven Harnblasenkarzinoms (NMIBC) stellt eine nicht abschließend gelöste Herausforderung an den…”
Get full text

Nutritional prevention of urological tumours by Schmitz-Dräger, B J, Sahin, S, Lümmen, G, Bismarck, E, Fischer, C

“…Through the last decade considerations on the role of vitamins and antioxidants in the primary prevention of genitourinary tumors have changed dramatically. In…”
Get more information

Supportive options in the treatment of urological tumours by Schmitz-Dräger, B J, Bismarck, E, Fischer, C

“…An ageing society with a consecutive increase of genitourinary malignancies along with remarkable changes in systemic cancer therapy provide the basis for an…”
Get more information

Expression of G1→S Transition Regulatory Molecules in Human Urothelial Cancer by Oya, Mototsugu, Schmidt, Bettina, Schmitz‐Dräger, Bernd J., Schulz, Wolfgang A.

“…Growth of cancer cells is characterized by accelerated passage through the cell cycle, which is often caused by deregulation of the G1→S transition. In this…”
Get full text

Chemoprevention of prostate cancer - a plea by Schmitz-Dräger, B J, Bismarck, E, Schöffski, O, Fischer, C

“…The high disease prevalence, the presentation in older age, a frequently slowly progressing course of disease, and high costs make the diagnosis of and therapy…”
Get more information

p53 immunohistochemistry as a prognostic marker in bladder cancer. Playground for urology scientists? by Schmitz-Dräger, B J, Goebell, P J, Ebert, T, Fradet, Y

“…Anomalies of the p53 tumor suppressor gene have been reported for a variety of different tumor types. Also in urothelial cancer accumulation of the P53 protein…”
Get more information

Prevention strategies for prostate cancer by Schmitz-Dräger, B J, Lümmen, G, Bismarck, E, Fischer, C

“…Through the last decade consideration of the role of vitamins and minerals in primary prevention of genitourinary tumors has dramatically changed. Despite all…”
Get more information

WAF1/p21 regulates proliferation, but does not mediate p53-dependent apoptosis in urothelial carcinoma cell lines by Makri, D, Schulz, W A, Grimm, M, Clasen, S, Bojar, H, Schmitz-Dräger, B J

“…The WAF1/p21 gene product is an inhibitor of cyclin-dependent kinases which can be induced by the tumor suppressor p53 and mediate some of its effects, or…”
Get more information